CDNA
CareDx, Inc · Healthcare · Medical - Diagnostics & Research
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 94 | +15 | 33.34M | $949.64M | +15 | −1 |
| Q1 2026 | 83 | +3 | 34.73M | $602.98M | +6 | −3 |
| Q4 2025 | 80 | +2 | 35.05M | $660.43M | +2 | — |
| Q3 2025 | 16 | -1 | 19.38M | $281.84M | — | −1 |
| Q2 2025 | 14 | -2 | 18.42M | $359.99M | — | −2 |
| Q1 2025 | 13 | -1 | 10.08M | $178.96M | — | −1 |
| Q4 2024 | 14 | 0 | 12.01M | $257.21M | +1 | −1 |
| Q3 2024 | 13 | +2 | 9.17M | $286.29M | +2 | — |
| Q2 2024 | 11 | — | 12.97M | $201.49M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 5.70M | — | $88.56M | 0.8% | n/c | 1 | SEC ↗ |
| 2 | Millennium Management ✦ | 2.14M | — | $33.25M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | D. E. Shaw & Co. ✦ | 1.73M | — | $26.83M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | D. E. Shaw & Co. ✦ | 1.73M | — | $26.83M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Renaissance Technologies ✦ | 1.51M | — | $23.49M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Geode Capital Management ✦ (pasivo) | 1.20M | — | $18.57M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Geode Capital Management ✦ (pasivo) | 1.20M | — | $18.57M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 202.31K | — | $3.14M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 202.31K | — | $3.14M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 180.06K | — | $2.80M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 180.06K | — | $2.80M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 180.06K | — | $2.80M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 120.50K | — | $1.87M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 105.98K | — | $1.65M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Marshall Wace ✦ | 55.71K | — | $865,192 | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Marshall Wace ✦ | 55.71K | — | $865,192 | 0.0% | n/c | 1 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 30.13K | — | $468,000 | 0.0% | n/c | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 189 tenedores, 52.20M acciones, $899.83M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.